Literature DB >> 9210030

Comprehensive investigation of the presence of JC virus in AIDS patients with and without progressive multifocal leukoencephalopathy.

P Ferrante1, R Caldarelli-Stefano, E Omodeo-Zorini, A E Cagni, L Cocchi, F Suter, R Maserati.   

Abstract

Progressive multifocal leukoencephalopathy (PML), a viral-induced demyelinating disease, is becoming relatively common, while many diagnostic and pathogenetic aspects remain to be clarified. A study was therefore undertaken in 64 AIDS patients suffering from various neurological disorders, including PML (12 subjects), with the specific objective of searching for JC virus (JCV) DNA by nested PCR (n-PCR) in cerebrospinal fluid (CSF), peripheral blood mononuclear cells (PBMCs), and urine collected from all patients. CSF examination, CD4 and CD8 counts, neurological examinations, and neuroradiological investigations were undertaken. JCV DNA was detected in 92% of CSF specimens in 75% of the PBMCs and urine samples from the PML patients, whereas among the non-PML patients JCV DNA was not detected in any CSF samples, but was found in 10% of PBMCs and in 39% of the urine specimens. BKV and JCV DNA viruria was observed simultaneously in 6% of the AIDS patients without PML. The routine CSF tests including IgG oligoclonal bands, the Link, and Tourtellotte IgG indexes, did not show a typical pattern in PML cases. The data obtained clearly indicate that the detection of JCV DNA in CSF constitutes an efficient marker for PML diagnosis. The simultaneous presence of JCV DNA in the CSF, PBMCs, and urine samples from the PML patients, who did not differ from controls with regard to their immunosuppressive status, suggests that JCV could be carried into the central nervous system (CNS) by infected PBMCs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9210030     DOI: 10.1002/(sici)1096-9071(199707)52:3<235::aid-jmv1>3.0.co;2-3

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  14 in total

1.  Increased frequency of JC virus type 2 and of dual infection with JC virus type 1 and 2 in Italian progressive multifocal leukoencephalopathy patients.

Authors:  P Ferrante; M Mediati; R Caldarelli-Stefano; L Losciale; R Mancuso; A E Cagni; R Maserati
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

2.  Immune reconstitution after allogeneic hematopoietic stem cell transplantation is associated with selective control of JC virus reactivation.

Authors:  Chen Sabrina Tan; Thomas A Broge; Long Ngo; Sarah Gheuens; Raphael Viscidi; Evelyn Bord; Jacalyn Rosenblatt; Michael Wong; David Avigan; Igor J Koralnik
Journal:  Biol Blood Marrow Transplant       Date:  2014-03-27       Impact factor: 5.742

3.  A humanized monoclonal antibody targeting the β7 integrin selectively blocks intestinal homing of T lymphocytes.

Authors:  E G Stefanich; D M Danilenko; H Wang; S O'Byrne; R Erickson; T Gelzleichter; H Hiraragi; H Chiu; S Ivelja; S Jeet; S Gadkari; O Hwang; F Fuh; C Looney; K Howell; V Albert; M Balazs; C Refino; S Fong; S Iyer; M Williams
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

4.  Immunoglobulin G, A, and M responses to BK virus in renal transplantation.

Authors:  Parmjeet S Randhawa; Gaurav Gupta; Abhay Vats; Ron Shapiro; Raphael P Viscidi
Journal:  Clin Vaccine Immunol       Date:  2006-09

5.  JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals.

Authors:  Raphael P Viscidi; Nina Khanna; Chen S Tan; Xiuhung Li; Lisa Jacobson; David B Clifford; Avindra Nath; Joseph B Margolick; Keerti V Shah; Hans H Hirsch; Igor J Koralnik
Journal:  Clin Infect Dis       Date:  2011-08-18       Impact factor: 9.079

Review 6.  Application of molecular tools for the diagnosis of central nervous system infections.

Authors:  Serena Delbue; Sara Tremolada; Pasquale Ferrante
Journal:  Neurol Sci       Date:  2008-09       Impact factor: 3.307

7.  JC virus viremia in interferon-beta -treated and untreated Italian multiple sclerosis patients and healthy controls.

Authors:  Serena Delbue; Franca Rosa Guerini; Roberta Mancuso; Domenico Caputo; Romina Mazziotti; Marina Saresella; Pasquale Ferrante
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

8.  JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients.

Authors:  Serena Delbue; Francesca Elia; Camilla Carloni; Valentina Pecchenini; Diego Franciotta; Matteo Gastaldi; Elena Colombo; Lucia Signorini; Silvia Carluccio; Anna Bellizzi; Roberto Bergamaschi; Pasquale Ferrante
Journal:  J Neurovirol       Date:  2014-07-23       Impact factor: 2.643

9.  Investigation of pre-diagnostic virological markers for progressive multifocal leukoencephalopathy in human immunodeficiency virus-infected patients.

Authors:  Mary K Grabowski; Raphael P Viscidi; Joseph B Margolick; Lisa P Jacobson; Keerti V Shah
Journal:  J Med Virol       Date:  2009-07       Impact factor: 2.327

10.  Lymphotropic polyomavirus is detected in peripheral blood from immunocompromised and healthy subjects.

Authors:  Serena Delbue; Sara Tremolada; Francesca Elia; Camilla Carloni; Serena Amico; Eleonora Tavazzi; Enrico Marchioni; Stefano Novati; Renato Maserati; Pasquale Ferrante
Journal:  J Clin Virol       Date:  2009-12-29       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.